Pulmonary embolism in patients with severe COVID-19 treated with intermediate- to full-dose enoxaparin: A retrospective study

Pulmonary embolism in patients with severe COVID-19 treated with intermediate- to full-dose enoxaparin: A retrospective study

Coronavirus disease (COVID-19) may predispose patients to pulmonary embolism (PE), despite standard thromboprophylaxis. Our retrospective study aimed to report the prevalence of PE in patients with COVID-19 and severe respiratory failure (SRF) treated with intermediate- to full-dose enoxaparin. We...

Full description

Bibliographic Details
Main Authors: Cleante Scarduelli, Francesco Inglese, Massimiliano Beccaria, Fabio Speafico, Martina Garuti, Antonietta Pecoriello, Giulia Cervi, Graziana Greco, Sara Scarduelli, Giuseppe Lucchini, Giuseppe De Donno, Claudio Borghi
Format: Article
Language:English
Published: PAGEPress Publications 2021-03-01
Series:Monaldi Archives for Chest Disease
Subjects:
pulmonary embolism
venous thromboembolism
COVID-19
enoxaparin
respiratory failure
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/1758

Internet

https://www.monaldi-archives.org/index.php/macd/article/view/1758

Similar Items